Belaunde CA, Romero RY, Díaz FJ

Language: Spanish
References: 16
Page: 1-5
PDF size: 755.88 Kb.

ABSTRACT

In December 2019, the 2019 coronavirus disease, produced by the type 2 coronavirus causing severe acute respiratory syndrome, was identified for the first time. More and more investigations are reporting the occurrence of systemic complications, some of them in a mediate or even late phase of the disease, when the patient has left the hospital. A 30-year-old healthy female patient who came to the hospital fourteen days after being discharged due to viral pneumonia secondary to SARS-COV-2. She presented with intense pain and distal coldness in the right lower limb, dyspnea at rest and pain in the left hypochondrium. The diagnosis at discharge was paradoxical pulmonary thromboembolism. Thrombotic complications should be taken into account in all convalescent COVID-19 patients. An early diagnosis is important to establish anticoagulation.

REFERENCES

1. Lu H, Stratton CW, Tang YW.Outbreak of pneumonia of unknownetiology in Wuhan, China:the mystery and the miracle. JMed Virol. [Internet]. 2020 [citado7/04/2021]; 92(4):401–402. Disponibleen: https://pubmed.ncbi.nlm.nih.gov/31950516/

2. Alhazzani W, Møller MH, ArabiYM, Loeb M, Gong MNg, Fan E,et al. Surviving sepsis campaign:guidelines on the management ofcritically ill adults with coronavirusdisease 2019 (COVID-19). CritCare Med. [Internet].2020 [citado7/04/2021]; 46(5):854-887. Disponibleen: https://pubmed.ncbi.nlm.nih.gov/32222812/

3. Ashraf O, Young M, Malik KJ,Cheema T. Systemic Complicationsof COVID-19. Critical Care NursingQuarterly. [Internet]. 2020 [citado7/04/2021]; 43(4):390-399. Disponibleen: https://covid19.elsevierpure.com/en/publications/systemic-complications-of-covid-19

4. Martínez Chamorro E, RevillaOstolaza TY, Pérez Núñez M,Borruel Nacenta S, Conde Rodríguez-Guerra C, Ibáñez Sanz L.Tromboembolismo pulmonar enpacientes con COVID-19: estudiode prevalencia en un hospital terciario.Radiología. [Internet]. 2021[citado 7/04/2021]; 63(1):13-21.Disponible en: https://www.sciencedirect.com/science/article/pii/S0033833820301405

5. Klok FA, Kruip MJHA, van derMeer NJM, Arbous MS, GommersDAMPJ, Kant KM, et al. Incidenceof thrombotic complicationsin critically ill ICU patients withCOVID-19.Thromb Res. [Internet].2020 [citado 7/04/2021];191(1):145–147. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146714/

6. Capilla Montes MT, Gómez CaravacaJ, Fernández Catalán C,Landaluce Chaves M, Mira Sirvent,Masegosa Medina JA. Embolismoparadójico: ¿una entidad infrecuenteo poco diagnosticada?Angiología. [Internet]. 2007 [citado 7/04/2021]; 59(6):451-456. Disponibleen: https://www.sciencedirect.com/science/article/abs/pii/S0003317007750824

7. Pons Pellicé L, Camio VisautaE, Chocron Da Prat I, RodríguezPalomares JF, Rosés Noguer F,de Nadal M. Ictus de la arteriacerebral media por embolia paradójicaen paciente con neumoníapor COVID-19. Rev Españolade Cardiología. [Internet]. 2021[citado 7/04/2021]; 74(6):558-559. Disponible en: https://www.revespcardiol.org/es-ictus-arteria-cerebral-media-por-articulo-S0300893220307041

8. Yu Z, Shanea Estes K, RamadanAli A, Alex Gandhi A, SrilakshmiYalavarthi, Hui Shi, et al. Prothromboticautoantibodies in serumfrom patients hospitalized withCOVID-19. Science TranslationalMedicine. [Internet]. 2020 [citado7/04/2021]; 12(570):eabd3876.Disponible en: https://stm.sciencemag.org/content/12/570/eabd3876

9. Puzzitiello RN, Pagani NR, MovermanMA, Moon AS, MenendezMA, Ryan SP. Inflammatory andcoagulative considerations forthe management of orthopaedictrauma patients with covid-19: areview of the current evidence andour surgical experience. Journalof Orthop Trauma. [Internet]. 2020[citado 7/04/2021]; 34(8):389-394. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302072/

10. Rogani S, Calsolaro V, FranchiR, Calabrese AM, Okoye C,Monzani F. Spontaneous musclehematoma in older patients withCOVID-19: two case reports andliterature review. BMC Geriatr. [Internet].2020 [citado 7/04/2021];20(539):[aprox. 14 p.]. Disponibleen: https://bmcgeriatr.biomedcentral.com/articles/10.1186/s12877-020-01963-4

11. Tabibkhooei A, Hatam J, MokhtariM, Abolmaali M. COVID-19-associatedspontaneous subacutesubdural haematoma: report oftwo cases. New Microbes and NewInfections. [Internet]. 2021 [citado7/04/2021]; 40(1):[aprox. 4 p.].Disponible en: https://www.sciencedirect.com/science/article/pii/S2052297521000123

12. Mazzitelli M, Serapide F, TassoneF, Laganà D, Trecarichi EM, TortiC.Spontaneous and Severe Haeestosmatomas in Patients with COVID-19on Low- Molecular-Weight Heparinfor Paroxysmal Atrial Fibrillation.Mediterr J Hematol Infect Dis. [Internet].2020 [citado 7/04/2021];12(1):e2020054. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340243/

13. Paranjpe I, Fuster V, Lala A,Russak A, Glicksberg BS, LevinMA, et al. Association of TreatmentDose Anticoagulation with In-HospitalSurvival among HospitalizedPatients with COVID-19. J Am CollCardiol. [Internet]. 2020 [citado7/04/2021]; 76(1):122–124. Disponibleen: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202841/

14. Jiménez Soto R, Montiel RomeroS, Neme Yunes Y, DemichelisGómez MR, Inclán Alarcón SI.Estrategias de anticoagulación enpacientes con COVID-19. Rev HematolMex. [Internet]. 2020 [citado7/04/2021]; 21(4):210-224. Disponibleen: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=97014

15. Loscalzo J. Paradoxical embolism:clinical presentation, diagnosticstrategies, and therapeutic options.Am Heart J. [Internet]. 1986[citado 7/04/2021]; 112(1):141-5.Disponible en: https://www.sciencedirect.com/science/article/abs/pii/0002870386906927

16. Ballvé Martín A, Boned S, RubieraM. Complicación trombótica deneumonía grave por COVID-19, ictuspor embolismo paradójico atípico.Rev. de neurol. [Internet]. 2020[citado 7/04/2021]; 71(5):186-190. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=7556548